Shopping Cart 0
Cart Subtotal
USD 0

Impax Laboratories Inc (IPXL)-Financial and Strategic SWOT Analysis Review

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Single User License
USD 125

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Site License
USD 250

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Deliverable Format : Excel, PDF Via Email

Corporate User License
USD 375
  • Details
  • Table Of Content
  • Licence Rights
  • Section Purchase
  • Products and Companies

Details

Impax Laboratories Inc (IPXL)-Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company's key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

Business description-A detailed description of the company's operations and business divisions.

Corporate strategy-Analyst's summarization of the company's business strategy.

SWOT Analysis-A detailed analysis of the company's strengths, weakness, opportunities and threats.

Company history-Progression of key events associated with the company.

Major products and services-A list of major products, services and brands of the company.

Key competitors-A list of key competitors to the company.

Key employees-A list of the key executives of the company.

Executive biographies-A brief summary of the executives' employment history.

Key operational heads-A list of personnel heading key departments/functions.

Important locations and subsidiaries-A list and contact details of key locations and subsidiaries of the company.

Key manufacturing facilities-A list of key manufacturing facilities of the company.

Detailed financial ratios for the past five years-The latest financial ratios derived from the annual financial statements published by the company with 5 years history.

Interim ratios for the last five interim periods-The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Impax Laboratories Inc (Impax) is a pharmaceutical company develops, manufacture and market generic and branded pharmaceuticals by applying its formulation expertise and drug delivery technology. The company operates develops and markets proprietary branded products for CNS disorders and manufactures and markets generic pharmaceutical products representing dosage variations of several pharmaceutical compounds. The company develops marketing partnerships to leverage its technology platform and to offer alternative dosage form technologies, such as nasal sprays, injectable, patches and others. It distributes its generic pharmaceutical products through wholesalers, large retail drug chains, unrelated third-party pharmaceutical entities and others. The company has manufacturing facilities in Hayward, California; Middlesex, New Jersey; and Taiwan. Impax is headquartered in Hayward, California, the US.

Impax Laboratories Inc Key Recent Developments

Mar 27,2017: Impax Board of Directors Appoints Paul M. Bisaro President and CEO

Mar 01,2017: Impax Reports Fourth Quarter and Full Year 2016 Financial Results

Dec 20,2016: Impax Laboratories Announces Leadership Transition

Nov 28,2016: Impax Laboratories appoints new board member

Nov 09,2016: Impax Reports Third Quarter 2016 Financial Results

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.

The profile analyzes the company's business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors' business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.

The company's core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.

Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies' strategic, financial and operational performance.

Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.

Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

READ MORE

Table Of Content

Scope

Table of Contents

Table of Contents 3

List of Tables 4

List of Figures 4

Section 1-About the Company 5

Impax Laboratories Inc-Key Facts 5

Impax Laboratories Inc-Key Employees 6

Impax Laboratories Inc-Key Employee Biographies 7

Impax Laboratories Inc-Major Products and Services 8

Impax Laboratories Inc-History 9

Impax Laboratories Inc-Company Statement 14

Impax Laboratories Inc-Locations And Subsidiaries 16

Head Office 16

Other Locations & Subsidiaries 16

Section 2-Company Analysis 18

Impax Laboratories Inc-Business Description 18

Impax Laboratories Inc-Corporate Strategy 19

Impax Laboratories Inc-SWOT Analysis 20

SWOT Analysis-Overview 20

Impax Laboratories Inc-Strengths 20

Impax Laboratories Inc-Weaknesses 21

Impax Laboratories Inc-Opportunities 22

Impax Laboratories Inc-Threats 23

Impax Laboratories Inc-Key Competitors 24

Section 3-Company Financial Ratios 25

Financial Ratios-Capital Market Ratios 25

Financial Ratios-Annual Ratios 26

Performance Chart 29

Financial Performance 29

Financial Ratios-Interim Ratios 30

Financial Ratios-Ratio Charts 31

Section 4-Company's Lifesciences Financial Deals and Alliances 32

Impax Laboratories Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 32

Impax Laboratories Inc, Pharmaceuticals & Healthcare, Deals By Type, 2011 to YTD 2017 33

Impax Laboratories Inc, Recent Deals Summary 34

Section 5-Company's Recent Developments 35

Mar 27, 2017: Impax Board of Directors Appoints Paul M. Bisaro President and CEO 35

Mar 01, 2017: Impax Reports Fourth Quarter and Full Year 2016 Financial Results 36

Dec 20, 2016: Impax Laboratories Announces Leadership Transition 39

Nov 28, 2016: Impax Laboratories appoints new board member 40

Nov 09, 2016: Impax Reports Third Quarter 2016 Financial Results 41

Aug 22, 2016: Richard A. Bierly Appointed to Impax Laboratories Board of Directors 43

Aug 09, 2016: Impax Reports Second Quarter 2016 Financial Results 44

Jul 21, 2016: Impax Names Douglas S. Boothe President of Generics Division 46

May 10, 2016: Impax Reports First Quarter 2016 Financial Results 47

Apr 14, 2016: Impax Announces the Retirement of Nigel Ten Fleming, Ph.D. and Michael Markbreiter from its Board of Directors 48

Section 6-Appendix 49

Methodology 49

Ratio Definitions 49

About GlobalData 53

Contact Us 53

Disclaimer 53


List Of Figure

List of Figures

Impax Laboratories Inc, Performance Chart (2012-2016) 30

Impax Laboratories Inc, Ratio Charts 32

Impax Laboratories Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 33

Impax Laboratories Inc, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 34


List Of Table

List of Tables

Impax Laboratories Inc, Key Facts 6

Impax Laboratories Inc, Key Employees 7

Impax Laboratories Inc, Key Employee Biographies 8

Impax Laboratories Inc, Major Products and Services 9

Impax Laboratories Inc, History 10

Impax Laboratories Inc, Other Locations 17

Impax Laboratories Inc, Subsidiaries 17

Impax Laboratories Inc, Key Competitors 25

Impax Laboratories Inc, Ratios based on current share price 26

Impax Laboratories Inc, Annual Ratios 27

Impax Laboratories Inc, Annual Ratios (Cont...1) 28

Impax Laboratories Inc, Annual Ratios (Cont...2) 29

Impax Laboratories Inc, Interim Ratios 31

Impax Laboratories Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 33

Impax Laboratories Inc, Pharmaceuticals & Healthcare, Deals By Type, 2011 to YTD 2017 34

Impax Laboratories Inc, Recent Deals Summary 35

Currency Codes 50

Capital Market Ratios 50

Equity Ratios 51

Profitability Ratios 51

Cost Ratios 52

Liquidity Ratios 52

Leverage Ratios 53

Efficiency Ratios 53

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

Products and Companies


Companies

Teva Pharmaceutical Industries Ltd, Sun Pharmaceutical Industries Ltd, Par Pharmaceutical Holdings Inc, Mylan NV, Mapi Pharma Ltd, Lupin Pharmaceuticals Inc, Lannett Company Inc, Avanir Pharmaceuticals Inc, Allergan Plc